Select conditions below to toggle them from the plot:
GROUP | CONDITION | SAMPLES |
---|---|---|
bladder cancer cell line 5637 |
GSM4579765 GSM4579767 GSM4579769
|
|
GSM4579766 GSM4579768 GSM4579770
|
||
bladder cancer cell line CLS-439 |
GSM4579777 GSM4579779 GSM4579781
|
|
GSM4579778 GSM4579780 GSM4579782
|
||
bladder cancer cell line T24 |
GSM4579759 GSM4579761 GSM4579763
|
|
GSM4579760 GSM4579762 GSM4579764
|
||
bladder cancer cell line TCC-SUP |
GSM4579771 GSM4579773 GSM4579775
|
|
GSM4579772 GSM4579774 GSM4579776
|
Submission Date: May 30, 2020
Summary: Mitomycin C (MMC) is the gold standard treatment for non-muscle invasive bladder cancer (NMIBC). We aimed to evaluate in bladder cancer cell lines (T24, 5637, TCC-SUP and CLS-439) the transcriptomic response to MMC treatment. We used Gene Set Enrichment Analysis (GSEA) to identify biological processes and pathways modulated by MMC treatment.
GEO Accession ID: GSE151505
PMID: 33408185
Submission Date: May 30, 2020
Summary: Mitomycin C (MMC) is the gold standard treatment for non-muscle invasive bladder cancer (NMIBC). We aimed to evaluate in bladder cancer cell lines (T24, 5637, TCC-SUP and CLS-439) the transcriptomic response to MMC treatment. We used Gene Set Enrichment Analysis (GSEA) to identify biological processes and pathways modulated by MMC treatment.
GEO Accession ID: GSE151505
PMID: 33408185
Signatures:
Control Condition
Perturbation Condition
Only conditions with at least 1 replicate are available to select
This pipeline enables you to analyze and visualize your bulk RNA sequencing datasets with an array of downstream analysis and visualization tools. The pipeline includes: PCA analysis, Clustergrammer interactive heatmap, library size analysis, differential gene expression analysis, enrichment analysis, and L1000 small molecule search.